Access cutting-edge chronic sinusitis treatment through this clinical trial at a research site in Charleston. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Charleston location
Preparing your pre-screening questions…
Access chronic sinusitis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic sinusitis treatment provided free
Check if you qualify for this chronic sinusitis clinical trial in Charleston, SC
No-Cost Study Care
Local to Charleston
Convenient for SC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The prevalence of Chronic Sinusitis with Nasal Polyps (CRSwNP) in the United States is estimated at roughly 4%, which equates to over 13 million Americans. Until recently, the only medical treatment options available for patients with CRSwNP were corticosteroids, with surgery reserved for medical failure. The development of biologic medications over the last 5 years has revolutionized the treatment of CRSwNP. Three biologic medications have been FDA approved and available for the treatment of CRSwNP: dupilumab, omalizumab, and mepolizumab. However, data from the clinical trials for these drugs do not show universal improvement across all patients with CRSwNP. In fact, there is a wide range of outcomes for patients in these trials. The result is that clinicians have no way of knowing which specific biologic would be the best option for any given patient, nor do they know whether biomarkers can be used to predict response to biologics. It is hoped that findings from this study will inform whether any one biologic has superior outcomes to another and whether clinicians can identify patients at baseline who are most likely to improve on biologic therapy.
Sponsor: Medical University of South Carolina
Yes, this clinical trial (NCT06824649) has an active research site in Charleston, SC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for chronic sinusitis treatment options in Charleston, SC, this clinical trial (NCT06824649) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Charleston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic sinusitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all chronic sinusitis clinical trials near you to find additional studies recruiting in your area.
See all interstitial cystitis clinical trials recruiting in Charleston — not just this study.
Browse Interstitial Cystitis Trials in Charleston →